Phase I study of SPN-809 in patients with depression
Latest Information Update: 19 Jul 2016
Price :
$35 *
At a glance
- Drugs Viloxazine (Primary)
- Indications Depression
- Focus Adverse reactions
- 19 Jul 2016 New trial record
Latest Information Update: 19 Jul 2016